Cargando…

The role of procalcitonin in identifying high‐risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score

BACKGROUND: The Multinational Association for Supportive Care in Cancer (MASCC) risk index has been utilized to determine the risk for poor clinical outcomes in patients with febrile neutropenia (FN) in an emergency center (EC). However, this index comprises subjective elements and elaborated metric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaftari, Patrick, Chaftari, Anne‐Marie, Hachem, Ray, Yeung, Sai‐Ching J., Dagher, Hiba, Jiang, Ying, Malek, Alexandre E., Dailey Garnes, Natalie, Mulanovich, Victor E., Raad, Issam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633259/ https://www.ncbi.nlm.nih.gov/pubmed/34725958 http://dx.doi.org/10.1002/cam4.4355

Ejemplares similares

859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023)

Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2022)

1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)

356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2021)

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: Haddad, Hanine El, et al.
Publicado: (2018)

Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: El Haddad, Hanine, et al.
Publicado: (2018)

363. A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia
por: Chaftari, Anne-Marie, et al.
Publicado: (2023)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021)

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2022)

Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection
por: Chaftari, Patrick, et al.
Publicado: (2021)

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy
por: Malek, Alexandre, et al.
Publicado: (2021)

528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients
por: Haddad, Andrea, et al.
Publicado: (2023)

Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
por: Dagher, Hiba, et al.
Publicado: (2023)

1769. The Impact of Checkpoint Inhibitor Immunotherapy on Infections in Lung Cancer Patients
por: Malek, Alexandre, et al.
Publicado: (2019)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection
por: Chaftari, Anne-Marie, et al.
Publicado: (2015)

Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

1709 Mycobacterium Arupense in Cancer Patients: A Commensal Organism or a Pathogen?
por: Jordan, Mary, et al.
Publicado: (2014)

Catheter-related Complications and Potential Risk Factors Among Catheterized Cancer Patients Receiving Parenteral Nutrition at The University of Texas MD Anderson Cancer Center: A 26,000 Parenteral Nutrition-day Experience
por: Reitzel, Ruth, et al.
Publicado: (2017)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections: Impact on Symptom Burden
por: Chaftari, Anne-Marie, et al.
Publicado: (2017)

293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
por: Chaftari, Anne-Marie, et al.
Publicado: (2021)

The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Foley Catheter with Peri-Urethral Antimicrobial Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – Assessment in an In Vitro Model
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
por: Dib, Rita Wilson, et al.
Publicado: (2018)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs)
por: Vargas-Cruz, Nylev, et al.
Publicado: (2019)

Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
por: Hemming, Victoria, et al.
Publicado: (2017)

Novel plasma telomerase detection method to improve cancer diagnostic assessment
por: Hilal, George, et al.
Publicado: (2017)

Management of enterococcal central line-associated bloodstream infections in patients with cancer
por: Awadh, Hesham, et al.
Publicado: (2021)

Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

2122. In Vitro Activity of Cefepime-Taniborbactam Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer
por: Gerges, Bahgat Z, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hk9r2ahcm8cl5l56seabt751as